Barclays
NGVT icon

Barclays’s Ingevity NGVT Stock Holding History

Barclays’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657K Sell
9,224
-49,881
-84% -$3.41M ﹤0.01% 3016
2025
Q4 		$3.5M Buy
59,105
+4,220
+8% +$229K ﹤0.01% 2502
2025
Q3 		$3.03M Sell
54,885
-18,878
-26% -$982K ﹤0.01% 2554
2025
Q2 		$3.18M Buy
73,763
+22,260
+43% +$859K ﹤0.01% 2498
2025
Q1 		$2.04M Sell
51,503
-17,769
-26% -$786K ﹤0.01% 2616
2024
Q4 		$2.82M Buy
69,272
+2,511
+4% +$105K ﹤0.01% 2641
2024
Q3 		$2.6M Buy
66,761
+47,429
+245% +$1.89M ﹤0.01% 2632
2024
Q2 		$845K Sell
19,332
-23,775
-55% -$1.15M ﹤0.01% 2702
2024
Q1 		$2.06M Sell
43,107
-27,852
-39% -$1.25M ﹤0.01% 2551
2023
Q4 		$3.35M Buy
70,959
+45,795
+182% +$1.9M ﹤0.01% 2463
2023
Q3 		$1.2M Buy
25,164
+938
+4% +$51.2K ﹤0.01% 2204
2023
Q2 		$1.41M Sell
24,226
-3,628
-13% -$218K ﹤0.01% 2100
2023
Q1 		$1.99M Buy
27,854
+9,453
+51% +$750K ﹤0.01% 2207
2022
Q4 		$1.3M Buy
18,401
+5,694
+45% +$401K ﹤0.01% 2590
2022
Q3 		$769K Buy
12,707
+8,050
+173% +$540K ﹤0.01% 2410
2022
Q2 		$293K Sell
4,657
-5,656
-55% -$369K ﹤0.01% 3211
2022
Q1 		$662K Sell
10,313
-46,527
-82% -$3.11M ﹤0.01% 2703
2021
Q4 		$4.08M Buy
56,840
+4,032
+8% +$307K ﹤0.01% 1859
2021
Q3 		$3.77M Buy
52,808
+20,465
+63% +$1.61M ﹤0.01% 1821
2021
Q2 		$2.63M Sell
32,343
-36,191
-53% -$2.91M ﹤0.01% 2008
2021
Q1 		$5.18M Buy
68,534
+2,135
+3% +$155K ﹤0.01% 1492
2020
Q4 		$5.03M Sell
66,399
-18,198
-22% -$1.19M ﹤0.01% 1523
2020
Q3 		$4.18M Buy
84,597
+5,881
+7% +$332K ﹤0.01% 1516
2020
Q2 		$4.14M Buy
78,716
+28,873
+58% +$1.37M ﹤0.01% 1515
2020
Q1 		$1.75M Buy
49,843
+1,499
+3% +$87.6K ﹤0.01% 2405
2019
Q4 		$4.22M Buy
48,344
+23,151
+92% +$2.02M ﹤0.01% 2192
2019
Q3 		$2.14M Sell
25,193
-11,153
-31% -$994K ﹤0.01% 2780
2019
Q2 		$3.82M Sell
36,346
-3,368
-8% -$338K ﹤0.01% 2133
2019
Q1 		$4.2M Buy
39,714
+12,155
+44% +$1.22M ﹤0.01% 1800
2018
Q4 		$2.31M Sell
27,559
-36,656
-57% -$3.32M ﹤0.01% 2266
2018
Q3 		$6.54M Buy
64,215
+46,424
+261% +$4.48M ﹤0.01% 1559
2018
Q2 		$1.44M Buy
17,791
+3,966
+29% +$315K ﹤0.01% 2881
2018
Q1 		$1.02M Sell
13,825
-861
-6% -$64.4K ﹤0.01% 3194
2017
Q4 		$1.04M Buy
14,686
+508
+4% +$36.7K ﹤0.01% 3082
2017
Q3 		$886K Buy
14,178
+616
+5% +$36.5K ﹤0.01% 3111
2017
Q2 		$779K Sell
13,562
-8,823
-39% -$519K ﹤0.01% 3098
2017
Q1 		$1.36M Sell
22,385
-49,846
-69% -$2.82M ﹤0.01% 2449
2016
Q4 		$3.96M Buy
72,231
+68,753
+1,977% +$3.3M ﹤0.01% 1556
2016
Q3 		$160K Sell
3,478
-1,791
-34% -$75.6K ﹤0.01% 4152
2016
Q2 		$180K Buy
+5,269
New +$165K ﹤0.01% 3993

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Barclays's NGVT Position: Q1 2026 in Review

Barclays reduced its Ingevity (NGVT) stake by 84% in Q1 2026, selling an estimated $3.41M and leaving 9,224 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Barclays first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $6.54M in Q3 2018. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Barclays held 9,224 shares of Ingevity worth $657K as of Q1 2026.
  • Barclays sold 49,881 Ingevity shares in Q1 2026, an estimated $3.41M.
  • Ingevity made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3016 holding.
  • Barclays first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • Barclays's Ingevity position peaked at $6.54M in Q3 2018.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.